NYSE$ATR

AptarGroup Inc. · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

AptarGroup's Q1 2021 results showcased sales growth and adjusted EPS increase, driven by strong performance in Food + Beverage segment amidst mixed market conditions.

AptarGroup reported an 8% increase in sales to $777 million for Q1 2021, with core sales up by 1%. Adjusted earnings per share totaled $1.09, a 10% increase compared to the prior year, neutralizing currency effects. The Food + Beverage segment demonstrated strong growth, while the Pharma and Beauty + Home segments experienced varied performance due to market-specific factors and pandemic-related impacts.

  • Reported sales increased by 8%, with core sales growing by 1%.
  • Earnings per share increased to $1.24, a 48% increase compared to the prior year.
  • Adjusted earnings per share rose to $1.09, reflecting a 10% increase from the prior year when neutralizing currency effects.
  • Strong performance in the Food + Beverage segment was driven by increased demand for food dispensing closures.

Headline financials

Total Revenue

$777M

Previous: $722M+7.7%
EPS (adj)

$1.09

Previous: $0.93+17.2%
Total Core Sales Growth

1.0%

Previous: -2.0%+150.0%
Pharma Core Sales Growth

0.0%

Previous: 7.0%-100.0%
Beauty Core Sales Growth

-3.0%

Previous: -9.0%+66.7%
Closures Core Sales Growth

14.0%

Previous: -2.0%+800.0%
Capital Expenditures

-$63.9M

Previous: -$61.6M-3.7%
Free Cash Flow

$20.1M

Previous: -$6.38M+414.6%
Net Income

$83.9M

Previous: $55.3M+51.9%
Operating Income

$92.6M

Previous: $88.5M+4.7%
Gross Profit

$777M

Previous: $722M+7.7%
Cash & Equivalents

$255M

Previous: $411M-38.0%
Total Assets

$3.99B

Previous: $3.78B+5.7%
Stock-Based Comp

$11.5M

Previous: $9.14M+25.7%

Revenue & EPS history

AptarGroup · Revenue · Quarterly

$777M

Q1 2021+7.7%vs Q1 2020
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

AptarGroup · $661M total across 2 segments · Q1 2021

  • Beauty
    $347M+6.9%
  • Pharma
    $314M+5.6%

Forward guidance

Aptar expects Q2 2021 earnings per share to be in the range of $0.91 to $0.99, excluding restructuring expenses and changes in the fair value of equity investments, based on an effective tax rate range of 26% to 28%.

Tailwinds

  • Easier comparisons to the prior year second quarter which was the period most severely impacted by pandemic lockdowns.
  • Positive mid and long-term view is unchanged, based on strong innovation and customer project pipelines.
  • Future is quite promising, and Aptar looks forward to growing each of its businesses for the long-term benefit of all stakeholders.
  • Strong innovation
  • Customer project pipelines

Headwinds

  • Demand for prescription drug and consumer health care devices will remain under pressure compared to the prior year as customers continue to work off existing inventories.
  • Results to be negatively impacted by the timing of passing through higher resin and other raw material costs.
  • Current underlying demand conditions in our markets are not expected to change dramatically from what was experienced in the first quarter.
  • Higher resin costs
  • Raw material costs

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+0.3%

Avg return

Earnings day

-0.1%

Avg return

5 days after

+1.2%

Avg return

30 days after

63%

43 / 68 earnings

Positive

+9.2%

Q4 2017

Best reaction

-9.0%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%-0.8%-6.4%
Q4 2025+8.3%+12.9%+6.5%
Q3 2025-9.0%-7.1%+0.3%
Q1 2025+2.3%+2.1%+6.8%
Q4 2024-8.5%-9.4%-2.3%
Q3 2024+0.8%+0.6%+2.3%
Q2 2024+1.7%+1.1%+4.4%
Q1 2024+2.4%+3.1%+5.8%
Q4 2023+5.4%+3.1%+8.6%
Q3 2023+0.1%-0.9%+4.2%
Q2 2023+3.2%+2.1%+6.3%
Q1 2023+2.4%+4.1%-1.4%
Q4 2022+5.7%+4.2%+0.3%
Q3 2022+2.1%-1.9%+6.9%
Q2 2022+1.6%+0.5%-1.5%
Q1 2022+3.4%+2.5%-2.0%
Q4 2021+3.3%+3.8%+2.7%
Q3 2021-3.6%+1.7%+1.0%
Q2 2021-6.3%-6.6%-2.3%
Q1 2021-0.2%+2.6%-2.5%
Q4 2020-7.7%-10.4%-2.7%
Q3 2020+1.6%+6.4%+13.3%
Q2 2020-3.0%-0.2%-0.6%
Q1 2020-3.6%-4.1%+1.2%
Q4 2019-2.6%-7.0%-19.6%
Q3 2019-7.1%-8.9%-6.0%
Q2 2019-5.0%-5.4%-1.3%
Q1 2019+1.3%+2.3%+2.0%
Q4 2018+1.5%+0.0%+2.2%
Q3 2018+1.8%+2.1%+2.0%
Q2 2018+8.6%+8.1%+9.6%
Q1 2018+0.3%+0.4%+1.0%
Q4 2017+9.2%+11.8%+9.6%
Q3 2017-0.6%-1.6%-2.5%
Q2 2017-6.5%-6.3%-6.4%
Q1 2017+1.2%+1.1%+6.3%
Q4 2016+1.7%+0.4%+4.4%
Q3 2016-4.3%-7.4%-0.3%
Q2 2016-1.9%-3.9%-1.6%
Q1 2016-3.1%
Q4 2015-2.8%
Q3 2015+2.4%
Q2 2015+8.3%
Q1 2015+2.4%
Q4 2014+1.8%
Q3 2014+2.0%
Q2 2014-3.5%
Q1 2014-0.1%
Q4 2013+1.9%
Q3 2013+0.2%
Q2 2013-2.1%
Q1 2013-2.0%
Q4 2012-0.8%
Q3 2012-3.5%
Q2 2012+2.6%
Q1 2012+0.9%
Q4 2011+0.1%
Q3 2011+5.8%
Q2 2011-5.0%
Q1 2010+2.2%
Q1 2011+2.3%
Q4 2008+1.5%
Q4 2010+1.5%
Q3 2010+2.9%
Q3 2009+2.9%
Q4 2009+0.5%
Q2 2009+0.5%
Q2 2010+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro